Back to today’s briefing

Story perspectives

Fatty Liver Disease Doubles Death Risk, Urgent Action Needed

3/25/2025

35 6

Summary

Karolinska Study Reveals

A groundbreaking study from Karolinska Institutet uncovers a startling truth: fatty liver disease, impacting one in five individuals in the UK, nearly doubles the risk of death. Patients grapple with alarming rates of liver disease, cancer, and heart problems. Early detection and comprehensive treatment are vital, as symptoms often go unnoticed until it's too late.

Summary

Study Revolutionizes Diagnosis

A groundbreaking study reveals that the acFibroMASH index outperforms traditional methods in diagnosing metabolic dysfunction-associated steatotic liver disease (MASLD). This innovative, non-invasive approach promises to spare patients from expensive liver biopsies. Coupled with the MRI-based LiverMultiScan, it significantly boosts diagnosis rates and offers a more affordable solution for patient care across Europe.

1 of 2

Karolinska Study Reveals

A groundbreaking study from Karolinska Institutet uncovers a startling truth: fatty liver disease, impacting one in five individuals in the UK, nearly doubles the risk of death. Patients grapple with alarming rates of liver disease, cancer, and heart problems. Early detection and comprehensive treatment are vital, as symptoms often go unnoticed until it's too late.

1 / 2